Logimedix is categorized under Mail Order Pharmaceuticals in Fort Lauderdale, FL and active since 2013.
Logimedix was established in 2013, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Robert Kusher, Owner at the company’s single location by writing to 15851 Sw 41st St # 700, Fort Lauderdale, Florida FL 33331 or by phoning (954) 349-9551. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Logimedix |
| Contact Person: | Robert Kusher, Owner |
| Address: | 15851 Sw 41st St # 700, Fort Lauderdale, Florida 33331 |
| Phone Number: | (954) 349-9551 |
| Website Address: | logimedix.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Mail Order Pharmaceuticals |
| SIC Code: | 5961 |
| NAICS Code: | 4234502 |
| Share This Business: |
Logimedix was started in 2013 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Robert Kusher, Owner for inquiries that concern Logimedix by calling the company number (954) 349-9551, as your correspondence is most welcome. Additionally, the physical location of the single location of Logimedix can be found at the coordinates 26.06835,-80.36141 as well as the street address 15851 Sw 41st St # 700 in Fort Lauderdale, Florida 33331.
For its online presence, you may visit Logimedix’s website at logimedix.com and engage with its social media outlets through on Twitter and on Facebook.